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Abstract 
Trichomoniasis, which is caused by Trichomonas vaginalis, is the most common 
non-viral sexually transmitted infection (STI) in the world including Iran. There 
were roughly 250 million new cases all over the world in a year. T. vaginalis as an 
important disease has been associated with HIV (in terms of exposure to sexually 
transmitted infection, STI) which increases the number of high-risk members, and 
thus it is an important public health problem. Additionally, this pathogen has been 
associated with serious health consequences. For instance, it may cause a woman to 
deliver a low-birth-weight or premature infant, and increase chances of cervical can-
cer. Because little information is available about the prevalence of T. vaginalis infec-
tion in Iranian population, this review was carried out to determine the prevalence of 
T. vaginalis among Iranian population. For this systematic review, data about epi-
demiology of T. vaginalis in different parts of Iran with different populations were 
systematically collected from 1992 to 2017 through the international databases such 
as PubMed, Scirus, ISI Web of Science, Scopus, EMBASE, Science Direct and 
Google Scholar and Islamic World Science Citation Center (ISC). National database 
searching included Iran Medex, Iran Doc, Magiran and Scientific Information Data-
base (SID). A total of 39 clinical and laboratory investigations about the prevalence 
of Trichomoniasis from different regions of Iran were analyzed. The overall preva-
lence rate of T. vaginalis infection in Iranian population was estimated to be mini-
mally 0.4% and maximally 42%. The present review showed that T. vaginalis infec-
tion rate is relatively high among the Iranian population. The control strategies, in-
cluding personal hygienic education, simultaneous couple treatment, the sensitivity 
of diagnostic methods, appropriate preventive tool (condom) in sexual contacts could 
lead to the disruption of transmission.  
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Introduction 
richomonas vaginalis is the causative agent 
of trichomoniasis, a non-ulcerative sexually 
transmitted disease. T. vaginalis is the pro- 
 
tozoan parasite infecting the urogenital tract of 
both females and males (1, 2). It is reported to be 
250 million new cases all over the world every 
year (3). Estimates of prevalence are differences 
between populations, but the range from 5-74% in 
women and 5-29% in men is observed (1).  
Women by the age of 16-53 are at greater risk of 
infection (4-6). Recently, different studies have  
 
 
 
 
 
shown that T. vaginalis has been associated with 
HIV, which increases the number of high-risk mem-
bers (7, 8). Additionally, this pathogen has been 
associated with serious health consequences; in-
cluding low-birth-weight in pregnant woman or 
premature infant and increased chances of cervical 
cancer. Women who are infected can be asymp-
tomatic or have different symptoms, consisting a 
yellowish-green frothy discharge purities, dysuria, 
and the strawberry cervix which is recognized by 
punctuates hemorrhagic lesions. In general, infec-
* Corresponding Author:  
Mohsen Arbabi,  
Department of Medical 
Parasitology and Mycology, 
School of Medicine, Kashan 
University of Medical  
Sciences, Kashan, Iran 
E-mail:  
arbabi4.mohsen@yahoo. 
com 
 
Received: Oct. 27, 2017 
Accepted: Feb. 24, 2018 
 
  
J Reprod Infertil, Vol 19, No 2, Apr-Jun 2018  83
                                                          Arbabi M, et al. JRI 
tion is asymptomatic in men, although it can be 
associated with urethral discharge and dysuria (1-
4). For diagnosis of trichomoniasis, different me-
thods have been used, such as, wet mount, culture, 
Papanicolaou smear, Pap smear, polymerase chain 
reaction (PCR) and serological tests. Wet mount 
tests are quick and straightforward. Specialized 
medium cultures are used for diagnosis, but 2-5 
days are required. Also, in some cases, parasites 
are diagnosed in the Papanicolaou smear. Moreo-
ver, the lack of sensitivity and specificity of sero-
logical examines is the major limitation for the 
detection of T. vaginalis by indirect serological 
testing. Recently, new approaches to diagnosis of 
parasite infections are provided by molecular bio-
logical methods. PCR allows the amplification of 
DNA fragments and diminishes the probability of 
misdiagnosis.  When few trophozoites are recog-
nized in a man’s reproductive organs, it is believ-
able that PCR is useful for the diagnosis of tricho-
moniasis (6-9). 5'-nitroimidazole family include 
metronidazole and tinidazole which are the most 
common drugs for treatment of trichomoniasis 
(10, 11). Because little information is available 
about the prevalence of T. vaginalis infection in 
Iranian population, this systematic review was 
carried out to determine the prevalence of T. 
vaginalis infection among Iranian population from 
1992 to 2017 through the electronic databases. 
 
Literature review of prevalence of trichomoniasis: 
For this systematic review, electronic searches in 
international and national databases and journals 
were conducted using key words of Trichomonas 
vaginalis, general population, prevalence, epide-
miology, and Iran.   
These articles had used at least one method (Di-
rect smear, culture, PCR, Pap smear) for epidemi-
ological study in different parts of Iran. Searches 
were performed through the international data-
bases such as PubMed, Scirus, ISI Web of Sci-
ence, Scopus, EMBASE, Science Direct, Google 
Scholar and Islamic World Science Citation Cen-
ter (ISC). National database searching included 
Iran Medex, Iran Doc, Magiran and Scientific In-
formation Database (SID). Articles that were pub-
lished between 1992 and 2017 were reviewed. 
Among the numerous information sources, rele-
vant studies on T. vaginalis infection were identi-
fied. Articles related to women with childbearing 
age who referred to health centers due to pregnan-
cy care and symptoms of vaginitis as well as gy-
necologic problems and men in different parts of 
Iran were included. A total of 39 papers were in-
vestigated and 3 articles related to women prison-
ers were excluded from the study. Due to high-
risk relationships and inappropriate health condi-
tions, the prevalence of vaginal Trichomoniasis in 
female prisoners is high and is different from 
normal rate in the society. Therefore, articles pub-
lished in the prison population were excluded. For 
this pathogenic parasitic protozoa, the studies 
were contradictory and generally of poor quality. 
At present, different methods have been used for 
recognizing Trichomoniasis, such as culture, Pap 
smear, polymerase chain reaction (PCR), and di-
rect smear. Thus, analysis of data was based on 
the diagnosis of T. vaginalis parasite in women 
who referred to health centers. Results were ob-
tained from different geographical areas classified 
and analyzed by descriptive statistics. 
Women referred to health centers in Sirjan 
(1992), Kashan (1993), Isfahan (1995) and Tabriz 
(1998) were infected with T. vaginalis (Direct 
smear: 2.2% and culture: 2.8%), (Culture: 2 
0.1%), (Direct smear: 1.49% and culture: 1.92%), 
(Direct smear: 22.6%), respectively (12-15). Pap 
smear specimens from women referring to health 
centers in Yasouj (1999) were 1.9% infected with 
T. vaginalis (16). In 1010 Pap smear specimens 
(1999) of 9.9% patients referring to Kashan, were 
infected with T. vaginalis (17). Pregnant women 
referring to health centers in Kashan (2000) and 
women referring to health centers in Zahedan 
(2001) and Hamedan (2001) were infected with T. 
vaginalis (Culture: 0.44%), (Direct smear: 4.5% 
and culture: 5.3%), (Direct smear: negative), re-
spectively (18-20). Result of the direct smear 
method and culture in pregnant women referring 
to health centers in Tehran (2002) showed 2.9% 
of patients were infected with T. vaginalis (21). 
Women referring to health centers in Gorgan 
(2003), Hamedan (2004) and Orumieh (2004) 
were infected with T. vaginalis (Direct smear and 
culture: 9%), (Direct smear: 2% and culture: 3%), 
(Direct smear: 2.4% and culture: 2.6%), respec-
tively (22-24). 63 women with symptoms of vagi-
nitis in Yasouj were surveyed using direct smear 
and culture methods  (2004) and the result showed 
19.04% and 42.9% of patients were infected with 
T. vaginalis, respectively (25). In the health center 
in Robat Karim (2005), patients were tested by 
direct smear and culture; results showed 1.4% of 
them were infected with T. vaginalis (26). Shar-
batdaran et al. used three methods of direct smear, 
culture and Pap smears for diagnosis of infection 
with T. vaginalis in Babol (2005) that 18.67%, 
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18.67% and 25.3% of women were infected re-
spectively (27). 0.9% infection with T. vaginalis 
was observed in 33690 Pap smear specimens in 
Kermanshah (2005) (28). A survey of women re-
ferring to health centers in Tabriz (2006), Yazd 
(2006), Tehran (2007) showed the percentage of 
infection with T. vaginalis using direct smear and 
culture was direct smear: 3.46 and culture: 4.56, 
direct smear: 1.2 and culture: 2.6%, direct smear 
and culture: 4, direct smear: 22.6, respectively 
(29-31). In a study that carried out among 300 
women referring to health centers of Shahrod 
(2008) using Pap smear and direct smear methods, 
only one case of T. vaginalis infection was report-
ed (32). A survey of Pap smear samples showed 
3.2% of women had a Trichomoniasis infection in 
the Sari health center (33). Study on women refer-
ring to Tehran health center (2009) was achieved 
using direct smear and culture and obtained result 
showed the percentage of infection was 2.6 and 
3.2, respectively (34). The infection rate of T. 
vaginalis in 160 women suspected of Trichomo-
niasis in Lorestan was 11.8% and 18.75% using 
direct smear and culture methods, respectively 
(35). From 1353 Pap smears specimens in Ahvaz 
(2010), 1.4% of patients were infected with T. 
vaginalis (36). In two studies in 2010 and 2011, 
percentage of T. vaginalis infection in women 
with childbearing age and pregnant women in 
Zanjan was 6.4 and 3.3, respectively (37, 38). 
PCR-SSCP method was used to test 950 samples 
from Hamadan and Tehran and obtained results 
showed fifty samples were positive (39). 3,500 
women referring to health centers in Tehran and 
Kashan were tested using direct smear, culture 
and PCR methods and 4% of them were infected 
(40). Patients in Kermanshah, Kashan and rural 
area of Shahrekord were infected with T. vagi-
nalis (Direct smear: 1.5% and culture: 2.1%), (Di-
rect smear and culture: 2%) and (Direct smear: 
4%), respectively (41-43). In 2014, women refer-
ring to Tehran health centers and Qom were in-
fected with T. vaginalis (Culture with urine sam-
ple of 5% and vaginal sample of 2.4%, PCR with 
urine sample of 8.2% and vaginal sample of 
8.7%) and (Direct smear: 2.67%, PCR:11.3%), 
respectively (44, 45) (Table 1). 
Estimates of prevalence of T. vaginalis between 
populations are different worldwide, but the range 
from 5-74% in women and 5-29% in men is ob-
served (1). The incidence of Trichomoniasis has 
increased remarkably especially in developing 
countries and in populations with high-risk behav-
iors such as poor sexual activity hygiene and mul-
tiple sexual partners. Poverty, socioeconomic sta-
tus, illiteracy, high risk sexual behaviors, and HIV 
positive are risk factors for infection of T. vagi-
nalis (46-49). In some studies, infection with T. 
vaginalis was more in illiterates than literates (12, 
13, 18, 27, 39, 42, 44). Low rate of infection with 
Trichomoniasis was observed among people who 
used condoms as a contraceptive method (12, 27, 
39, 44), whereas in some studies, Trichomoniasis 
was not related to prevention methods (13, 14, 
42). The reports of Trichomoniasis in Iran are dif-
ferent just the same as other parts of the world. 
The difference in the prevalence of infection may 
depend on the selection of population groups, 
methods and the site of specimen collection. 
Symptomatic Trichomoniasis is less common in 
men than women. Biological differences between 
the two sexes are the cause that women have a 
higher incidence of infection compared to men 
(50, 42). Sex hormone is a major factor in differ-
ent prevalence of Trichomoniasis between both 
sexes (42). Infection in women can be either 
asymptomatic or symptomatic, while, it is asymp-
tomatic in men (1-4). Diagnosis of Trichomoni-
asis on the basis of clinical examinations indicates 
88% false negative and 29% false positive results 
(40). On the basis of some studies, clinical symp-
toms such as burning and itching were associated 
with Trichomoniasis (12, 14, 18, 22, 24, 27, 39, 
44), while these results were in contrast with other 
studies (13, 29, 42). Direct smear is the most com-
mon method for diagnosis of this infection. After 
taking samples, they must be tested quickly be-
cause the parasite stops moving in a short period 
and will cause false negative results. The standard 
method in diagnosis of Trichomoniasis is culture. 
As this method is sensitive, appropriate conditions 
including ingredients of culture media, culture 
temperature, incubation time and the rapid trans-
mission of the parasite after sampling to culture 
medium are required. Before reporting negative 
results, negative specimens should be keep up to 7 
days for more evaluation. But this method is not 
used as a routine diagnosis since it wastes much 
time (44). Typical symptomatic Trichomoniasis in 
men is cleared spontaneously within 10 days. On 
the other hand, infection in women can persist for 
years. Therefore, recognition of carriers is very 
important for accelerating treatment and decreas-
ing the spread of the disease in control strategies 
(48, 49). One of the most sensitive diagnostic 
techniques is polymerase chain reaction (PCR).  
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Table 1. Prevalence of T. vaginalis in different parts of Iran from 1992 to 2017 
 
City Method Study population Year Prevalence 
Sirjan Direct smear and culture 500 women referred to health centers 1992 Direct smear: 2.2%, Culture: 2.8% 
Kashan Culture 900 women referred to health centers 1993 Culture:2.1% 
Esfahan Direct smear and culture 470 women referred to health centers 1995 Direct smear:1.49%, Culture:1.92% 
Tabriz Direct smear 469 women referred to health centers 1998 Direct smear: 22.6% 
Yasouj Pap smear 1942 Pap smear cytology samples section 1999 Pap smear:1.9% 
Kashan Pap smear 1010 Pap smear cytology samples section 1999 Pap smear: 9.9% 
Kashan Culture 450 pregnant women referred to health centers 2000 Culture:0.44% 
Zahedan Direct smear and culture 597 women referred to health centers 2001 Direct smear:4.5%, culture:5.3% 
Hamedan Direct smear 31 women admitted to the psychiatric ward 2001 Direct smear: negative 
Tehran Direct smear and culture Pregnant women referred to hospital 2002 Direct smear and culture: 2.9% 
Gorgan Direct smear and culture 102 women referred to health centers 2003 Direct smear and culture: 9% 
Hamedan Direct smear and culture 400 women referred to health centers 2004 Direct smear:2%, culture:3% 
Orumieh Direct smear and culture 420 women referred to health centers 2004 Direct smear:2.4%, culture:2.6% 
Yasouj Direct smear and culture and clinical signs 63 women with symptoms of vaginitis 2004 
Clinical signs:19.04%,  direct smear and cul-
ture:42.9% 
Robat Karamu Direct smear and culture 500 women referred to health centers 2005 Direct smear and culture:1.4% 
Babol Direct smear and culture and  Pap smear 150 women with clinical signs 2005 
Direct smear:18.67%, culture:18.67%, Pap 
smear: 25.3% 
Kermanshah Pap smear 33690 Pap smear specimens in clinic 2005 Pap smear: 0.9% 
Tabriz Direct smear and culture 2630 women referred to health centers 2006 Direct smear:3.46%, Culture: 4.56% 
Yazd Direct smear and culture 384 women referred to health centers 2006 Direct smear:1.2%, Culture: 2.6% 
Tehran Direct smear and culture 150 women referred to health centers 2007 Direct smear and culture:4% 
Shahrod Pap smear and direct smear 300 women referred to health centers 2008 Pap smear and direct smear: Only 1 
Sari Pap smear 1832 Pap smear in women referred to health centers 2008 Pap smear: 3.2% 
Tehran Direct smear and culture 500 women referred to health centers 2009 Direct smear: 2.6% , Culture: 3.2% 
Lorestan Direct smear and culture 160 women suspected of Trichomoniasis 2010 Direct smear:11.8%, Culture:18.75% 
Ahvaz Pap smear 1353 Pap smear in women referred to health centers 2010 Pap smear:1.4% 
Zanjan Direct smear 328 women referred to health centers 2010 Direct smear: 6.4% 
Zanjan Direct smear and culture 1000 pregnant women 2011 Direct smear and culture:3.3% 
Hamadan and 
Tehran PCR-SSCP 950 women referred to health centers 2011 PCR-SSCP: Fifty T. vaginalis samples 
Kashan and 
Tehran 
Direct smear , culture 
and PCR 3500 women referred to health centers 2011 Direct smear , culture and PCR:4% 
Kermanshah Direct smear and culture 600 women referred to health centers 2011-2012 Direct smear1.5%, culture:2.1% 
Kermanshah Direct smear and culture 600 women referred to health centers 2012 Direct smear:1.5%, culture:2.1% 
Kermanshah Pap smear and direct smear 1100 women referred to health centers 
2006-
2012 Pap smear and direct smear: 0.63% 
Kashan Direct smear and culture 970 women and 235 men referred to health centers 2013 Direct smear and culture :2% 
Shahrekord Direct smear 92 rural women 2014 Direct smear:4% 
Tehran Culture and PCR 140 women referred to health centers  2014 
Culture: urine sample: 5%, vaginal sample: 2.4%, 
PCR: urine sample: 8.2% , vaginal sample: 8.7% 
Qom Direct smear and PCR 300 women referred to health centers 2014 Direct smear: 2.67%,  PCR:11.3% 
Ardabil Direct smear and culture 904 women referred to health centers 2014 Direct smear: 3.38%, culture: 4.48% 
Hamadan Direct smear  and cul-ture 1200 women referred to health centers 2015 Direct smear: 0.3%, culture: 0.6% 
Hamadan Direct smear and culture 862 women referred to health centers 2015 Direct smear and culture:1.9% 
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For better chances of accurate diagnosis, at least 
two techniques are needed, such as wet mount 
microscopy and culture. Although PCR is found 
to be highly specific and sensitive, it is costly to 
be used in routine diagnostic laboratories (42, 49, 
51). Based on reviewing research conducted in 
Iran, studies have used at least one detection 
method (Pap smear, direct smear, culture and 
PCR) (41-55). Among the articles, only 12 articles 
had used a detection method while the other re-
maining articles used at least 2 or 3 detection 
methods (12-45, 52-55). Research done among 
various groups of women indicates that the preva-
lence is different between  women admitted to the 
psychiatric ward and women with symptoms of 
vaginitis from zero to 42.9%, respectively (21, 
26). Results of this systematic review shows the 
considerable rate of Trichomoniasis in Iran is re-
lated to lack of appropriate control programs in 
different parts of the country. Control of T. vagi-
nalis could have considerable public health bene-
fits in controlling both HIV and sexual diseases in 
women. This approach needs to be conducted in 
large communities, with particular attention to 
high-risk groups. Screening or empiric treatment 
is not only needed in high-risk groups, but also is 
needed in low-risk groups like pregnant women. 
 
Conclusion 
The present review showed that T. vaginalis in-
fection rate is relatively high among the Iranian 
population. Range of control strategies, including 
personal hygienic education, simultaneous couple 
treatment, the sensitivity of diagnostic methods, 
appropriate preventive tool (condom) in sexual 
contacts could lead to the disruption of transmis-
sion. Using at least two techniques such as culture 
or PCR in addition to direct smear is recommend-
ed for better diagnosis of infection and under-
standing the actual prevalence of T. vaginalis. 
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